NVAX241220C8000
- 1.12
- -0.17-13.18%
Novavax Newsroom
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
Institutional Investors Control 53% of Novavax, Inc. (NASDAQ:NVAX) and Were Rewarded Last Week After Stock Increased 6.3%
Novavax Analyst Ratings
H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Novavax, Inc. (NVAX) Is Attracting Investor Attention: Here Is What You Should Know
Express News | Novavax Inc - Working With FDA on Potential Accelerated Approval
Express News | Novavax Inc: Intends to Partner on Both Candidates to Advance to Filing and Commercialization
Express News | Novavax Initiates Phase 3 Trial for Covid-19-Influenza Combination and Stand-Alone Influenza
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA
Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.
Express News | Reuters Agriculture & Energy Policy Reporter Leah Douglas Posts On X "SCOOP: The USDA Is Issuing a Federal Order Mandating the National Milk Supply Be Tested for Bird Flu. Testing Will Begin Dec. 16 in Six States: CA, CO, MI, MS, PA, OR. Bird Flu Has...
Novavax Call Volume Above Normal and Directionally Bullish
US stocks move | Selling Czech factory, novavax (NVAX.US) rises over 12%.
As of the time of writing, the stock has risen over 12%, reported at $9.355.
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22
When Will Novavax, Inc. (NASDAQ:NVAX) Breakeven?
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Powell Speech